Redwire Stock Rises Despite Fugazi Short Report Flagging Dilution, Cash Burn
Redwire Corp (NYSE:RDW) shares are trading higher Monday morning, shrugging off a short report from Fugazi Research that argued the space...
Alphabet Stock Jumps 3%: Google Parent Replaces Verizon in Historic Dow Jones Milestone
Google parent Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOG) stock traded higher by over 3% on Monday as risk appetite stays firm in big-cap tech....
Here’s How Much $1000 Invested In Hewlett Packard 10 Years Ago Would Be Worth Today
Hewlett Packard (NYSE:HPE) has outperformed the market over the past 10 years by 1.68% on an annualized basis producing an average annual return of...
Strategy Sells $1.2B In MSTR, Buys 0 Bitcoin: What’s Going On?
Strategy Inc. (NASDAQ:MSTR) sold $1.2 billion worth of its own stock last week without buying a single Bitcoin (CRYPTO: BTC), holding steady at...
Ouster Stock Is Surging Monday: What’s Driving The Action?
Ouster Inc (NASDAQ:OUST) shares are trading higher by more than 15% Monday morning, despite a lack of company-specific news for the session....
Rocket Lab Just Became More Like SpaceX—And Less Like A Rocket Company
Rocket Lab Corp. (NASDAQ:RKLB) made headlines with its $8 billion acquisition of satellite communications provider Iridium Communications Inc....
Decoy Stock Rises After Announcing Up to $21 Million Private Placement Financing
Decoy Therapeutics Inc. (NASDAQ:DCOY) shares are trading higher. The company announced a $21 million private placement financing with a healthcare...
Trump Bought Up To $5 Million In Axon Stock Weeks Before ICE Sought $220 Million Taser Contract: Report
President Donald Trump reportedly bought up to $5 million worth of shares in Axon Enterprise (NASDAQ:AXON) — the maker of Tasers, body cameras, and...
Apple Tests Pricing Power As Component Costs Quadruple: Where Is AAPL Stock Headed?
Apple Inc (NASDAQ:AAPL) shares are trading marginally higher Monday morning as AI-driven supply crunch headlines keep the focus on component...
FDA Manufacturing Issues Delay Lantheus’ Tumor Imaging Kit
On Friday, the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter to Lantheus Holdings Inc.’s (NASDAQ:LNTH) New Drug...
Tom Lee’s BitMine Buy 27,084 ETH, But BMNR Hits Fresh Lows: What’s Going On?
Bitmine Immersion Technologies (NYSE:BMNR) bought 27,084 Ethereum (CRYPTO: ETH) last week, pushing total holdings to 5.70 million ETH, even as the...
EXCLUSIVE: AMASS Targets Protein Craze With HpO Deal
AMASS Brands Group (NASDAQ:AMSS) said Monday it plans to acquire a majority stake in sparkling protein water brand HpO, expanding its presence in...
Nasdaq Jumps More Than 1%; Comcast Shares Spike Higher
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 1% on Monday. Following the market opening Monday, the Dow...
Airline Stocks Spent 6 Years Below Covid Highs: Hormuz Snapped That Trend In Two Months
The U.S. Global Jets ETF (NYSE:JETS), the most widely watched gauge of global aviation, climbed 13.5% in June. That’s the best performance of any...
Viridian Secures First FDA Approval, Sets Up Challenge To Amgen’s Tepezza For Thyroid Eye Disease
The U.S. Food and Drug Administration on Friday approved Viridian Therapeutics Inc.’s (NASDAQ:VRDN) new thyroid eye disease (TED) treatment, Lumvoa...